0081-CC MassCheck® Immunosuppressants Whole Blood Controls
- 公司名稱 北京祥生興業(yè)科技有限公司
- 品牌 CHROMSYSTEMS
- 型號 0081-CC
- 產(chǎn)地
- 廠商性質 代理商
- 更新時間 2025/6/13 14:32:06
- 訪問次數(shù) 463
聯(lián)系方式：張先生13681184382 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
溫馨提示：僅用于科研，不可用于臨床治療
- 供應商：
祥生興業(yè)
- 英文名：
MassCheck® Immunosuppressants Whole Blood Control, Four-Level (I+II+III+IV) 4 x 2 x 2 ml
- 規(guī)格：
4 x 2 x 2 ml
MassCheck® Immunosuppressants Whole Blood Controls
Order No.: 0081/0082/0083/0084/0085/0089
Parameters:
Cyclosporin A, Everolimus, Sirolimus, Tacrolimus
MassCheck® Immunosuppressants Whole Blood Controls, lyophilised
For MassTox® Immunosuppressants in Whole Blood (93000, 93900, 93900/1200/F)
0081 Four-Level, 4 x 2 x 2 ml
0082 Level I, 5 x 2 ml
0083 Level II, 5 x 2 ml
0084 Level III, 5 x 2 ml
0085 Level IV, 5 x 2 ml
0089 Blank Control, 5 x 2 ml
These lyophilised quality controls from Chromsystems are based on human material and are carried in the routine together with the corresponding test series. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of the analytes.
The controls should be handled and measured in the same way as patient specimens. Please refer to the instruction manual for the exact procedure.
| Concentrations | Please note: Concentration values shown here are exemplary! For the concentration values of production lot specific please refer to the product information leaflet.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Method of Analysis | LC-MS/MS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Parameter | Cyclosporin A, Everolimus, Sirolimus, Tacrolimus | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
采購中心
化工儀器網(wǎng)